Reasons for surgical treatment of polycystic ovary syndrome
Gomel, V.
Journal de Gynecologie Obstetrique et Biologie de la Reproduction 32(3 Part 2): S46-S49
2003
ISSN/ISBN: 0368-2315 PMID: 12773919 Document Number: 559845
Document emailed within 1 workday
Related Documents
Kachalina, T.S.; Dobrotina, A.F. 1988: Reproductive function following the surgical treatment of polycystic ovary syndrome Akusherstvo i Ginekologiia 5: 62-63Alieva, E.A.; Pshenichnikova, T.I.; Gasparov, A.S.; Danchenko, O.V. 1992: Diagnostic and surgical laparoscopy in polycystic ovary syndrome Akusherstvo i Ginekologiia 2: 61-64
Gandar, R.; Spizzo, M.; Collin, D. 1999: Diagnosis and treatment of polycystic ovary syndrome Journal de Gynecologie Obstetrique et Biologie de la Reproduction 28(6): 510-518
Starup, J. 1976: Treatment of patients with polycystic ovary syndrome. i Ugeskrift for Laeger 138(46): 2866-2870
Barbieri, R.L.; Gargiulo, A.R. 2004: Metformin for the treatment of the polycystic ovary syndrome Minerva Ginecologica 56(1): 63-79
Starup, J. 1976: Treatment of patients with polycystic ovary syndrome. Ii Ugeskrift for Laeger 138(46): 2863-2866
Bell, D.S.H. 2007: Treatment of infertility in the polycystic ovary syndrome New England Journal of Medicine 356(19): 1999-2000; Author Reply 2000-2001
Anwary, S.A.; Alfazzaman, M.; Bari, N.; Islam, M.R. 2012: Outcome of metformin treatment in polycystic ovary syndrome Mymensingh Medical Journal: Mmj 21(1): 60-65
Olszanecka-Glinianowicz, M.; Zahorska-Markiewicz, B.; Jochemczyk-Banek, U.; Banaś, M.ł; Zurakowski, A. 2004: Sibutramine administration in polycystic ovary syndrome treatment Ginekologia Polska 75(6): 470-474
Petrányi, G. 2005: Treatment experience with metformin in polycystic ovary syndrome Orvosi Hetilap 146(21): 1151-1155
Teede, H.J.; Meyer, C.; Norman, R.J. 2005: Insulin-sensitisers in the treatment of polycystic ovary syndrome Expert Opinion on PharmacoTherapy 6(14): 2419-2427
Blum, I.; Kaufman, H.; Marilus, R.; Rusecki, Y.; Chovers, I. 1981: Successful treatment of polycystic ovary syndrome with spironolactone or bromocriptine Obstetrics and Gynecology 57(5): 661-665
Wang, H.-S. 2006: The role of metformin in the treatment of polycystic ovary syndrome (PCOS) Chang Gung Medical Journal 29(5): 445-447
Sayin, N.Cenk.; Gücer, F.; Balkanli-Kaplan, P.; Yüce, M.Ali.; Ciftci, Sürk.; Kücük, M.; Yardim, T. 2003: Elevated serum TNF-alpha levels in normal-weight women with polycystic ovaries or the polycystic ovary syndrome Journal of Reproductive Medicine 48(3): 165-170
Presl, J. 1984: The direct effect of insulin on the ovary and the pathogenesis of the polycystic ovary syndrome Ceskoslovenska Gynekologie 49(2): 124-125
Spritzer, P.M.; Motta, A.B. 2015: Adolescence and polycystic ovary syndrome: current concepts on diagnosis and treatment International Journal of Clinical Practice 69(11): 1236-1246
Wang, D.Z.; Wang, Z.Q.; Shi, L.Y. 1988: Treatment of polycystic ovary syndrome with Chinese drug longdan xiegan tang Journal of Traditional Chinese Medicine 8(2): 117-119
Cibula, D.; Kuzel, D.; Rezabek, K.; Vrbikova, J.; Zivny, J.; Starka, P.L. 2000: Multiple ovarian biopsy in the treatment of women with polycystic ovary syndrome (PCOS) Clinical and Experimental Obstetrics and Gynecology 27(3-4): 194-196
Pechlivanov, B. 2010: Myo-inositol in the treatment of hormonal, metabolic and reproductive features of polycystic ovary syndrome (review of the literature Akusherstvo i Ginekologiia 49(3): 37-39
Beltadze, K.; Barbakadze, L. 2015: Ovarian reserve in the women of late reproductive age after conservative treatment of polycystic ovary syndrome in adolescence Georgian Medical News 238: 27-31